The immune system is our body’s natural defense, a system that has evolved over thousands of years, adapting to the different environments to which the human body has been exposed.
The immune system is made up of a complex network of specialized cells that interact with each other to protect the body from any type of threat. There are diseases such as Cancer, HIV (AIDS) or Diabetes, which suppress our immune system leaving it vulnerable to the progression of the disease or any other type of threat.
At Omsana Health we integrate a series of therapies focused on the stimulation of the immune system, so that the patient’s body is able to generate an effective anti-tumor response, against the cancer cells in their body.
Integrative immunotherapy approaches aim to optimize the immune system to enhance the effects of conventional immunotherapy and improve outcomes for cancer patients. These therapies can help to reduce side effects, enhance immune function, and improve overall well-being.
By combining conventional immunotherapy with integrative therapies, cancer patients may experience a more comprehensive and individualized approach to treatment that addresses not only the disease, but also the person as a whole.
Working with a healthcare professional who is knowledgeable in both conventional and integrative treatments at Omsana Health can help patients create a personalized treatment plan that best fits their needs and goals.
-Natural Killers Cell Activators
-Therapy with Oriental Mushroom Extracts
Hyperthermia is an alternative therapy that involves heating the body to a temperature between 40 and 44 degrees Celsius to treat cancer. The increased temperature can kill cancer cells and also stimulate the immune system to fight the disease. Hyperthermia can be used alone or in combination with other cancer treatments, such as chemotherapy and radiation therapy. The therapy can be applied locally, such as by inserting a probe directly into the tumor, or regionally, by heating a larger area of the body. The goal of hyperthermia is to improve treatment outcomes while minimizing side effects, and it has shown promising results in some studies.
Hyperthermia can be a valuable complement to conventional cancer treatments, as it can enhance their effects and reduce the need for high doses of chemotherapy and radiation therapy. Additionally, hyperthermia is a non-toxic therapy that can be used alongside other holistic and alternative treatments. Integrating hyperthermia with other complementary therapies such as nutrition and exercise, can further improve the body’s ability to fight cancer, enhance overall well-being, and improve quality of life. While hyperthermia may not work for everyone, it can be an important tool in the treatment of cancer and may provide hope for those who are seeking alternatives to conventional treatments.
One type of hyperthermia is called whole-body hyperthermia (WBH), which involves heating the entire body to a controlled temperature. WBH can help activate the immune system, which can aid in the fight against cancer cells, and also promote detoxification and healing.
Additionally, WBH can help alleviate side effects from chemotherapy and radiation therapy, such as nausea and fatigue. WBH is typically administered in a clinical setting, and it is important to work with a qualified healthcare professional who is experienced in hyperthermia treatments to ensure safe and effective care. With the growing interest in alternative and holistic treatments, hyperthermia may offer a new approach to cancer treatment that can benefit patients in their journey towards healing.
Selenium works by protecting cells from oxidative damage and by regulating DNA repair and synthesis. Additionally, selenium has been shown to inhibit the growth of cancer cells and induce apoptosis, or programmed cell death, in cancer cells.
It is an essential trace element which must be consumed in the diet. This trace element has many functions in our body, but as far as immunostimulation is concerned it has been found that a supplement of 200 micrograms of selenium daily, stimulate the lymphocyte cell line especially the Natural Killer Cells, promote cell phagocytosis in our body, and stimulate the migration of immune cells to the area of injury.
This protocol is implemented for 3 weeks in our clinic and its continuation will depend on the patient’s response.
Protocol with Melatonin
Melatonin has been identified as a promising natural and holistic anti-cancer therapy due to its potent anti-cancer effects. The hormone has been shown to induce cancer cell death, reduce cancer cell proliferation, and inhibit tumor growth.
Additionally, melatonin’s antioxidant properties help to neutralize harmful free radicals that can cause cellular damage and contribute to the development of cancer.
As a natural substance produced by the body, melatonin is generally safe and well-tolerated, making it an attractive option for individuals seeking complementary cancer treatments.
While melatonin is not a cure for cancer on its own, it can complement other conventional cancer therapies, and its use as part of a holistic cancer protocol has shown promising results in improving patient outcomes.
The activation of immune cells, in this case macrophages, can be by different mechanisms, on the one hand, by direct recognition (pathogen-cell) or by activation by immunomodulatory proteins.
Vitamin D Binding Protein (VDBP) is a protein produced in the liver. And the function for which it was named is for the transport of vitamin D metabolites, this being one of its many functions. In 1991, Dr. Nobuto Yamamoto began to describe the various functions in which this protein participated, such as being a precursor of the Macrophage Activating Factor (MAF), indispensable for an effective immune response, thus maintaining a balance in our system. In addition to being a precursor for macrophage activation, this activator protein has been shown to decrease the formation of blood vessels (angiogenesis) in tumor development, decreasing the energy supply to cancer cells, thus slowing their metabolism and slowing their progression.
During certain pathological conditions such as cancer, it has been demonstrated that in the affected cells there is an increase in the production of an enzyme called N-alpha-acetylgalactosaminidase also known as Nagalase, this enzyme degrades the Vitamin D transporter protein (VDBP), decreasing its bioactivity and reducing the activation of macrophages in the antitumor response, thus limiting the reaction of these immune cells, creating an ideal environment for the development of cancer cells.
Dr. Yamamoto was able to produce an analog of this protein which he named Gc-MAF (Glycoprotein-Macrophage Activating Factor). Today there is extensive research on its use in multiple pathological conditions including cancer, due to the immunological and antitumor mechanisms in which it has been shown to be involved.